Last deal

$33.04M
Local Amount - GBP 26M

Amount

Series B

Stage

29.01.2024

Date

3

all rounds

$97.09M

Total amount

date founded

Financing round

General

About Company
Enterprise Therapeutics develops novel therapies for respiratory diseases.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2014

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

The company focuses on discovering disease-modifying therapies that target the underlying mechanisms of mucus congestion in respiratory diseases such as cystic fibrosis, asthma, and COPD. This approach aims to reduce the frequency of lung infections and improve patient quality of life. The leadership team has extensive expertise in drug discovery and respiratory biology, and the company collaborates closely with the School of Life Sciences at the University of Sussex.
Legal Names

Legal name

Enterprise Therapeutics Limited
Similar Companies
1000
Altair Therapeutics

Altair Therapeutics

Altair Therapeutics develops and sells antisense drugs for respiratory diseases like asthma.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

San Diego, CA, USA

total rounds

2

total raised

$23.47M
Modus Therapeutics

Modus Therapeutics

Modus Therapeutics develops pharmaceutical therapies to restore impaired blood flow in rare diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Stockholm, Sweden

total rounds

4

total raised

$21.14M
Enalare Therapeutics

Enalare Therapeutics

Enalare Therapeutics Inc. develops and commercializes novel therapies for acute respiratory and critical care conditions.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Biotechnology, Therapeutics

Location

Naples, FL, USA

total rounds

6

total raised

$73.85M
Revivo Therapeutics

Revivo Therapeutics

Revivo Therapeutics develops new therapeutic agents for major neurological diseases, focusing on Alzheimer's Disease.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Durham, NC, USA

Financials

Funding Rounds
8
3

Number of Funding Rounds

$97.09M

Money Raised

Their latest funding was raised on 29.01.2024. Their latest investor IP Group. Their latest round Series B

Date 
Funding Round 
Investors 
Money Raised 
Lead 
29.01.2024
6
$33.04M
Local Amount - GBP 26M
09.03.2022
5
$4.13M
Local Amount - GBP 5.25M
15.10.2019
1
$7.27M
Local Amount - GBP 5.7M
Panakes Partners

Panakes Partners

Panakes Partners is a Venture Capital investor that finances medical companies, startups, and high growth SMEs in Europe and Israel.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Medical Device

Location

Milan, Metropolitan City of Milan, Italy

count Of Investments

29
Cystic Fibrosis Foundation

Cystic Fibrosis Foundation

Cystic Fibrosis Foundation is a non-profit foundation that aims to cure cystic fibrosis and improve the lives of people with the disease.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Non-Profit, Health Care

Location

Bethesda, MD, USA

total rounds

1

count Of Investments

54

count Of Exists

3
Co-Investors
Investors
9
7

Number of lead investors

9

Number of investors

Investor 
Lead 
Round 
Partners 
No
Debt Financing, Series B
Yes
Debt Financing, Series B, Venture - Series Unknown
Yes
Debt Financing, Series B
IP Group

IP Group

IP Group creates value for shareholders and partners by commercialising intellectual property from research institutions.

Sector

General Industrials

Subsector

Diversified Industrials

Location

London, UK

total rounds

1

total raised

$30M

count Of Investments

248

count Of Exists

15
Epidarex Capital

Epidarex Capital

Epidarex Capital is a venture capital firm that invests in early-stage life science and health technology companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Biotechnology, Financial Services

Location

Bethesda, MD, USA

count Of Investments

39

count Of Exists

2
Versant Ventures

Versant Ventures

Versant Ventures is a healthcare investment firm that helps entrepreneurs build great companies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Medical Device, Venture Capital, Health Care

Location

Menlo Park, CA, USA

count Of Investments

289

count Of Exists

61

People

Founders
1
Henry Danahay
Henry Danahay

Henry Danahay

Dr Henry Danahay gained a BPharm and PhD from the Welsh School of Pharmacy before joining the Novartis Respiratory Diseases Group. Whilst with Novartis, he worked as an in vitro/in vivo pharmacologist with a specialisation in airway epithelial cell based drug targets. During this time he played a central role in establishing the CF discovery portfolio and was most recently Director and Head of the Lung Repair & Regeneration Group in the Respiratory Disease Area. He has lead a number of drug discovery programs from target identification through to early clinical studies as well as authoring >40 peer reviewed papers and patents. As a co-founder of Enterprise Therapeutics, Dr Danahay is Head of Biology and is an honorary Senior Research Fellow at the University of Sussex.

current job

Enterprise Therapeutics
Enterprise Therapeutics

organization founded

1

Henry Danahay

Employee Profiles
8
Niyati Prasad

Niyati Prasad

Chief Medical Officer

David Morris

David Morris

Chief Medical Officer

Amit D. Munshi

Amit D. Munshi

Chairman, Board of Directors

John Ford

John Ford

CEO

Henry Danahay

Henry Danahay

Head of Biology

Peter Finan

Peter Finan

Enterprise Therapeutics

Martin Gosling

Martin Gosling

CSO

Activity

Recent News
3
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

week